After years of declining peritoneal dialysis (PD) utilization in the United States,1 a large increase in incident PD use from 6.6% in 2009 to 12.3% in 2019 has occurred.2 In 2019, 16.9% of patients were receiving PD at 1 year after dialysis initiation. Two health care reform initiatives—the end-stage renal disease prospective payment system that launched in 20113,4 and, more recently, the Advancing American Kidney Health (AAKH) initiative5—are likely to facilitate continued PD growth. The former created a reimbursement structure that financially incentivized increasing PD use over center-based hemodialysis, whereas the AAKH initiative has established targets aimed at increasing home-based dialysis.